SHMT2 decreased, while SHMT2α increased stem cell like features of ovarian cancer cells, as identified by spheroid formation ability (Fig. 4C, D), expression of stemness markers CD44 and CD133 (Fig. 4E). The gene discussed is CD44; the disease is ovarian cancer.